Publications:322
Paolo Cravedi, MD
About Me
Paolo Cravedi, MD, PhD, is Professor of Medicine in the Division of Nephrology and the Director of the Translational Transplant Research Center (TTRC). Dr. Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. His initial studies have contributed to defining the organ allocation system currently used in many countries around the world. Dr. Cravedi was involved in the design and implementation of the first mechanistic clinical studies testing the safety/efficacy profile of B cell depletion in subjects with membranous nephropathy or focal segmental glomerulosclerosis (FSGS).
In 2011, Dr. Cravedi joined Icahn School of Medicine at Mount Sinai, where he started working on the effects of complement and erythropoietin in adaptive immune response. He is interested in implementing new technologies to study alloimmune responses and, more recently, his work has been testing the immune effects of fasting in transplantation.
p.p1 {margin: 0.0px 0.0px 6.0px 0.0px; text-align: justify; font: 12.0px Arial}Language
English
Position
PROFESSOR | Medicine, Nephrology
Publications
Selected Publications
- Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases. Lorenza Magagnoli, Sofia Bin, Paolo Cravedi, Mario Cozzolino. Clinical Kidney Journal
- CKD remission and even regression: a vision reaffirmed. Paolo Cravedi, Giuseppe Remuzzi, Piero Ruggenenti. Kidney International
- Narrative Review of Preparative Regimens Predictive of Mixed Chimerism After HLA-Mismatched Hematopoietic Stem Cell Transplantation: A Starting Point for Combined Solid Organ and Stem Cell Transplantation. Roberto Crocchiolo, Ilaria Gandolfini, Paolo Cravedi, Giulia Di Maggio, Elena Borotti, Giovanni Rombolà, Lucia Prezioso, Paola Zanelli, Umberto Maggiore. Transplantation Proceedings
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Cravedi has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.